Pykus Therapeutics' PYK-2101 achieves positive interim clinical trial results

FDA accepts Novo Nordisk's filing application for oral semaglutide 25 mg

Nutshell Therapeutics' NTS071 p53 allosteric reactivator cleared for US clinical trial

Genmab to submit US sBLA for epcoritamab combination therapy in relapsed/refractory follicular lymphoma

Blue Earth Therapeutics initiates Phase 2 trial in metastatic castrate resistant prostate cancer

Armata Pharmaceuticals' AP-SA02 clinical trial receives additional US DoD funding

BioArctic receives SEK101.7m in royalties from Q1 Leqembi sales

SKNV launches Kefunova Cream for actinic keratosis and superficial basal cell carcinoma

Ingenium Therapeutics' Gengleucel to enter Phase 2 trial in MRD+ AML following FDA feedback

Nuformix receives positive EMA opinion for orphan drug designation of NXP002 in IPF

Johnson & Johnson secures FDA approval for IMAAVY, expanding treatment options for generalised myasthenia gravis

MHRA to review monthly maintenance dosing for Leqembi in early Alzheimer's treatment

Ro integrates with NovoCare Pharmacy to offer access to all doses of Wegovy at lowest price

Myosin Therapeutics receives grant to advance MT-110 clinical trial in methamphetamine use disorder

CSL Vifor and Travere Therapeutics gain full EU approval for FILSPARI in IgA nephropathy